Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
EBITDA Margin % is calculated as EBITDA divided by its Revenue. Bon Natural Life's EBITDA for the
six
months ended in Sep. 2025 was $-1.26 Mil. Bon Natural Life's Revenue for the
six
months ended in Sep. 2025 was $10.72 Mil. Therefore, Bon Natural Life's EBITDA margin for the quarter that ended in Sep. 2025 was -11.75%.
Bon Natural Life (NAS:BON) EBITDA Margin % Explanation
EBITDA Margin % is the ratio of EBITDA divided by net sales or Revenue. It is an performance metric measuring company's operating profitability. EBITDA Margin takes depreciation and amortization, interest expense and tax into account, which makes it easy to compare the relative profitability of companies of different sizes in the same industry.
Bon Natural Life EBITDA Margin % Related Terms
Bon Natural Life EBITDA Margin % Historical Data
* Premium members only.
The historical data trend for Bon Natural Life's EBITDA Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
BON vs SNES, YMAT, GLGI: EBITDA Margin % Comparison
For the Specialty Chemicals subindustry, Bon Natural Life's EBITDA Margin %, along with its competitors' market caps and EBITDA Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Bon Natural Life EBITDA Margin % vs Chemicals Industry
For the Chemicals industry and Basic Materials sector, Bon Natural Life's EBITDA Margin % distribution charts can be found below:
* The bar in red indicates where Bon Natural Life's EBITDA Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Bon Natural Life (BON) has a EBITDA Margin % of -11.75% as of Sep. 2025. EBITDA Margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent. View historical data on Bon Natural Life and its competitors. According to the industry distribution chart, Bon Natural Life ranks #1310 out of 1577 companies in the Chemicals industry, placing it in the top 83.1%.
Is Bon Natural Life's EBITDA Margin % too high?
Bon Natural Life's current EBITDA Margin % is -11.75%. Based on the distribution chart, Bon Natural Life ranks #1310 out of 1577 companies in the Chemicals industry, which is in the bottom quartile relative to peers. Overall, Bon Natural Life has a GF Score™ of 42/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Bon Natural Life's EBITDA Margin % compare to SNES and YMAT?
According to the Chemicals industry distribution chart, Bon Natural Life ranks #1310 out of 1577 companies for EBITDA Margin %. This places Bon Natural Life in the lower half of its industry. The industry median EBITDA Margin % is 9.64. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EBITDA Margin % for a Chemicals company?
The median EBITDA Margin % among Chemicals companies is 9.64, based on 1,577 companies in the industry. Companies in the top quartile (top 25%) have a EBITDA Margin % significantly above this median, while those in the bottom quartile fall well below. However, EBITDA Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EBITDA Margin % mean?
A high EBITDA Margin % can signal that a stock is expensive relative to its fundamentals. EBITDA Margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent. View historical data on Bon Natural Life and its competitors. For the Chemicals industry, the median EBITDA Margin % is 9.64 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Bon Natural Life's current EBITDA Margin % is -11.75%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Bon Natural Life stock overvalued right now?
Based on GuruFocus' analysis, Bon Natural Life (BON) is currently considered Significantly Overvalued. The stock's GF Value™ is $0.76, compared to a current price of $1.14 — trading 50% above its estimated fair value. The current EBITDA Margin % is -11.75%. Bon Natural Life's overall GF Score™ is 42/100 with 9 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EBITDA Margin % calculated?
EBITDA Margin % is calculated from a company's financial statements. For Bon Natural Life (BON), the current EBITDA Margin % is -11.75% as of Sep. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Bon Natural Life (BON) Overvalued in 2026?
Based on GuruFocus' analysis, Bon Natural Life stock appears to be overvalued.
The current stock price of $1.14 is trading 50% above its estimated GF Value™ of $0.76.
GuruFocus considers Bon Natural Life to be Significantly Overvalued.
Key valuation signals for BON:
EBITDA Margin %: -11.75%
GF Value™: $0.76 vs. price of $1.14 (50% above fair value)
No single metric tells the full story. See the BON stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Bon Natural Life Ltd focuses on the manufacturing of personal care ingredients, such as plant extracted fragrance compounds to perfume and fragrance manufacturers, natural health supplements such as powder drinks and bioactive food ingredient products mostly used as food additives and nutritional supplements by its customers. It has developed four technology platforms for large-scale separation, safety improvement, activity enhancement, and functional compounding of natural products. The company's offerings include Fragrance compounds, Health supplements, and Bioactive food ingredients. The company generates revenue from the sale of its products, the majority derived from the sale of Fragrance compounds, which include natural compounds extracted from plants for cosmetic applications.
42GF Score
Get the complete analysis for BON
EBITDA Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
BON has been successfully added to your 
